SCP
GILD icon

Stamos Capital Partners’s Gilead Sciences GILD Stock Holding History

Stamos Capital Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$854K Buy
6,763
+975
+17% +$128K 0.13% 121
2026
Q1 		$807K Sell
5,788
-1,498
-21% -$210K 0.13% 121
2025
Q4 		$894K Buy
7,286
+2,566
+54% +$312K 0.14% 124
2025
Q3 		$524K Sell
4,720
-2,963
-39% -$337K 0.1% 127
2025
Q2 		$852K Buy
7,683
+59
+0.8% +$6.28K 0.15% 119
2025
Q1 		$854K Sell
7,624
-5,826
-43% -$601K 0.22% 110
2024
Q4 		$1.24M Sell
13,450
-19,510
-59% -$1.76M 0.29% 99
2024
Q3 		$2.76M Sell
32,960
-10,350
-24% -$790K 0.65% 41
2024
Q2 		$2.97M Buy
43,310
+6,750
+18% +$450K 0.63% 37
2024
Q1 		$2.68M Buy
36,560
+5,960
+19% +$458K 0.61% 40
2023
Q4 		$2.48M Sell
30,600
-14,710
-32% -$1.14M 0.67% 44
2023
Q3 		$3.4M Buy
45,310
+870
+2% +$66.9K 0.76% 36
2023
Q2 		$3.42M Buy
44,440
+7,020
+19% +$560K 0.8% 32
2023
Q1 		$3.1M Buy
37,420
+5,670
+18% +$470K 0.8% 37
2022
Q4 		$2.73M Sell
31,750
-15,900
-33% -$1.26M 0.86% 32
2022
Q3 		$2.94M Buy
47,650
+26,450
+125% +$1.67M 0.75% 40
2022
Q2 		$1.31M Hold
21,200
– – 0.4% 51
2022
Q1 		$1.26M Buy
+21,200
New +$1.36M 0.42% 44
2021
Q1 		– Sell
-50,700
Closed -$2.95M – 48
2020
Q4 		$2.95M Buy
+50,700
New +$3.06M 1.26% 27
2020
Q2 		– Sell
-13,454
Closed -$1.01M – 72
2020
Q1 		$1.01M Buy
+13,454
New +$930K 0.53% 58
2019
Q3 		– Sell
-3,600
Closed -$244K – 47
2019
Q2 		$244K Buy
+3,600
New +$237K 0.24% 50

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Stamos Capital Partners's GILD Position: Q2 2026 in Review

Stamos Capital Partners increased its Gilead Sciences (GILD) stake by 17% in Q2 2026, buying an estimated $128K and bringing the position to 6,763 shares worth $854K. The position accounts for 0.13% of the portfolio, ranked #121.

Stamos Capital Partners first reported a position in GILD in Q2 2019 and has held it in 21 quarters since. The position peaked at $3.42M in Q2 2023. 2,284 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Stamos Capital Partners held 6,763 shares of Gilead Sciences worth $854K as of Q2 2026.
  • Stamos Capital Partners bought 975 Gilead Sciences shares in Q2 2026, an estimated $128K.
  • Gilead Sciences made up 0.13% of Stamos Capital Partners's portfolio in Q2 2026, its #121 holding.
  • Stamos Capital Partners first reported a position in Gilead Sciences in Q2 2019 and has held it in 21 quarters since.
  • Stamos Capital Partners's Gilead Sciences position peaked at $3.42M in Q2 2023.
  • 2,284 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Stamos Capital Partners's 13F filing for Q2 2026, filed 13 Aug 2026.